Ozempic Litigation Update: Where We Stand in December 2025

If you are following the lawsuits regarding Ozempic, Wegovy, and Mounjaro (MDL 3094), you likely want to know if a settlement is on the horizon.

As we end 2025, case numbers are rising, but strict new rulings have raised the bar for plaintiffs.

1. The "Testing" Requirement (Crucial Update)

The most significant development this year was a ruling by Judge Marston regarding gastroparesis (stomach paralysis) claims.

• The Change: It is no longer sufficient to have a diagnosis based solely on symptoms like nausea or vomiting.

• The Requirement: Plaintiffs must now provide objective diagnostic testing—specifically a gastric emptying study—to prove their injury.

2. Emerging Claims: Vision Loss

While stomach issues remain the primary focus, attorneys are increasingly filing cases regarding NAION (sudden vision loss/blindness). Studies released earlier this year linked semaglutide to this condition, and these claims are distinct from the gastric requirements mentioned above.

3. Timeline: When to Expect Settlements

Mass tort litigation can be slow. Based on the current court schedule:

• Current Case Count: 2,900+ pending cases.

• Next Milestone: "Bellwether" (test) trials are expected to begin in late 2026.

• Settlement Outlook: Large-scale settlements generally occur only after test trials. Realistically, we could be looking past 2026 for a potential resolution.

The Bottom Line: The Ozempic litigation is active, and if you have a claim the time to act is now!